This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merlino, G T
Right arrow Articles by Roe, B A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merlino, G T
Right arrow Articles by Roe, B A

 Previous Article  |  Next Article 

Mol Cell Biol. 1985 July; 5(7): 1722-1734

Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells.

G T Merlino, S Ishii, J Whang-Peng, T Knutsen, Y H Xu, A J Clark, R H Stratton, R K Wilson, D P Ma and B A Roe

ABSTRACT

A431 cells have an amplification of the epidermal growth factor (EGF) receptor gene, the cellular homolog of the v-erb B oncogene, and overproduce an aberrant 2.9-kilobase RNA that encodes a portion of the EGF receptor. A cDNA (pE15) for the aberrant RNA was cloned, sequenced, and used to analyze genomic DNA blots from A431 and normal cells. These data indicate that the aberrant RNA is created by a gene rearrangement within chromosome 7, resulting in a fusion of the 5' portion of the EGF receptor gene to an unidentified region of genomic DNA. The unidentified sequences are amplified to about the same degree (20- to 30-fold) as the EGF receptor sequences. In situ hybridization to chromosomes from normal cells and A431 cells show that both the EGF receptor gene and the unidentified DNA are localized to the p14-p12 region of chromosome 7. By using cDNA fragments to probe DNA blots from mouse-A431 somatic cell hybrids, the rearranged receptor gene was shown to be associated with translocation chromosome M4.

Mol Cell Biol. 1985 July; 5(7): 1722-1734




This article has been cited by other articles:

  • Hong, Y.-S., Deming, S. L., Gao, Y.-T., Long, J.-R., Shu, X.-O., Cai, Q., Lu, W., Zheng, W. (2009). A Two-stage Case-Control Study of EGFR Polymorphisms and Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev. 18: 680-683 [Full Text]  
  • Milano, G., Etienne-Grimaldi, M.-C., Dahan, L., Francoual, M., Spano, J.-P., Benchimol, D., Chazal, M., Letoublon, C., Andre, T., Gilly, F.-N., Delpero, J.-R., Formento, J.-L. (2008). Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer. Ann Oncol 19: 2033-2038 [Abstract] [Full Text]  
  • Albitar, L., Laidler, L. L., Abdallah, R., Leslie, K. K. (2005). Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type I and II tumors. Molecular Cancer Therapeutics 4: 1891-1899 [Abstract] [Full Text]  
  • Pao, W., Miller, V. A. (2005). Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non-Small-Cell Lung Cancer: Current Knowledge and Future Directions. JCO 23: 2556-2568 [Abstract] [Full Text]  
  • Liu, W., Innocenti, F., Wu, M. H., Desai, A. A., Dolan, M. E., Cook, E. H. Jr., Ratain, M. J. (2005). A Functional Common Polymorphism in a Sp1 Recognition Site of the Epidermal Growth Factor Receptor Gene Promoter. Cancer Res. 65: 46-53 [Abstract] [Full Text]  
  • Amador, M. L., Oppenheimer, D., Perea, S., Maitra, A., Cusati, G., Iacobuzio-Donahue, C., Baker, S. D., Ashfaq, R., Takimoto, C., Forastiere, A., Hidalgo, M. (2004). An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors. Cancer Res. 64: 9139-9143 [Abstract] [Full Text]  
  • Liu, W., Innocenti, F., Chen, P., Das, S., Cook, E. H. Jr., Ratain, M. J. (2003). Interethnic Difference in the Allelic Distribution of Human Epidermal Growth Factor Receptor Intron 1 Polymorphism. Clin. Cancer Res. 9: 1009-1012 [Abstract] [Full Text]  
  • Baron, A. T., Lafky, J. M., Suman, V. J., Hillman, D. W., Buenafe, M. C., Boardman, C. H., Podratz, K. C., Perez, E. A., Maihle, N. J. (2001). A Preliminary Study of Serum Concentrations of Soluble Epidermal Growth Factor Receptor (sErbB1), Gonadotropins, and Steroid Hormones in Healthy Men and Women. Cancer Epidemiol. Biomarkers Prev. 10: 1175-1185 [Abstract] [Full Text]  
  • Buerger, H., Gebhardt, F., Schmidt, H., Beckmann, A., Hutmacher, K., Simon, R., Lelle, R., Boecker, W., Brandt, B. (2000). Length and Loss of Heterozygosity of an Intron 1 Polymorphic Sequence of egfr Is Related to Cytogenetic Alterations and Epithelial Growth Factor Receptor Expression. Cancer Res. 60: 854-857 [Abstract] [Full Text]  
  • Bredel, M., Pollack, I. F., Hamilton, R. L., James, C. D. (1999). Epidermal Growth Factor Receptor Expression and Gene Amplification in High-Grade Non-Brainstem Gliomas of Childhood. Clin. Cancer Res. 5: 1786-1792 [Abstract] [Full Text]  
  • Gebhardt, F., Zanker, K. S., Brandt, B. (1999). Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1. J. Biol. Chem. 274: 13176-13180 [Abstract] [Full Text]  
  • Baron, A. T., Lafky, J. M., Boardman, C. H., Balasubramaniam, S., Suman, V. J., Podratz, K. C., Maihle, N. J. (1999). Serum sErbB1 and Epidermal Growth Factor Levels As Tumor Biomarkers in Women with Stage III or IV Epithelial Ovarian Cancer. Cancer Epidemiol. Biomarkers Prev. 8: 129-137 [Abstract] [Full Text]  
  • O'Bryan, J. P., Fridell, Y.-W., Koski, R., Varnum, B., Liu, E. T. (1995). The Transforming Receptor Tyrosine Kinase, Axl, Is Post-translationally Regulated by Proteolytic Cleavage. J. Biol. Chem. 270: 551-557 [Abstract] [Full Text]  
  • Hashimoto, T, Amagai, M, Parry, D., Dixon, T., Tsukita, S, Tsukita, S, Miki, K, Sakai, K, Inokuchi, Y, Kudoh, J, et, al. (1993). Desmoyokin, a 680 kDa keratinocyte plasma membrane-associated protein, is homologous to the protein encoded by human gene AHNAK. J. Cell Sci. 105: 275-286 [Abstract]  
  • Merlino, G T, Stahle, C, Jhappan, C, Linton, R, Mahon, K A, Willingham, M C (1991). Inactivation of a sperm motility gene by insertion of an epidermal growth factor receptor transgene whose product is overexpressed and compartmentalized during spermatogenesis.. Genes Dev. 5: 1395-1406 [Abstract]  
  • Rovigatti, U, Watson, D., Yunis, J. (1986). Amplification and rearrangement of Hu-ets-1 in leukemia and lymphoma with involvement of 11q23. Science 232: 398-400 [Abstract]  
  • Park, M., Gonzatti-Haces, M., Dean, M., Blair, D.G., Testa, J.R., Bennett, D.D., Copeland, T., Oroszlan, S., Vande Woude, G. (1986). The met Oncogene: A New Member of the Tyrosine Kinase Family and a Marker for Cystic Fibrosis. Cold Spring Harb Symp Quant Biol 51: 967-975 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»